Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.

October 17, 2018 admin CEO Interview, Healthcare Comments Off on Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.

tetra logo

 

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

 

 

Guy Chamberland

 

 

 

 

 

Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.

Investor Presentation Deck
Tetra Investor Presentation




Related Articles

CEO Interview

The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF) Building brands “At the intersection of cannabis & wellness”

April 5, 2019 admin CEO Interview, Spotlight Stocks Comments Off on The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF) Building brands “At the intersection of cannabis & wellness”

  Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of […]

Healthcare

CytoDyn (OTC: CYDY) Announces Webcast for its Annual Meeting of Stockholders

September 6, 2019 admin Healthcare, Newsmakers Comments Off on CytoDyn (OTC: CYDY) Announces Webcast for its Annual Meeting of Stockholders

VANCOUVER, Washington, Sep 06, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that […]

Newsmakers

Check-Cap (NASDAQ: CHEK) Announces Pricing of $17.5 Million Upsized Underwritten Public Offering

May 5, 2018 admin Newsmakers Comments Off on Check-Cap (NASDAQ: CHEK) Announces Pricing of $17.5 Million Upsized Underwritten Public Offering

ISFIYA, Israel, May 04, 2018 — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW, CHEKZ), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, […]